Zhang, J.; Nishida, Y.; Koike, H.; Zhuo, L.; Ito, K.; Ikuta, K.; Sakai, T.; Imagama, S.
Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo. Int. J. Mol. Sci. 2023, 24, 12422.
https://doi.org/10.3390/ijms241512422
AMA Style
Zhang J, Nishida Y, Koike H, Zhuo L, Ito K, Ikuta K, Sakai T, Imagama S.
Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo. International Journal of Molecular Sciences. 2023; 24(15):12422.
https://doi.org/10.3390/ijms241512422
Chicago/Turabian Style
Zhang, Jiarui, Yoshihiro Nishida, Hiroshi Koike, Lisheng Zhuo, Kan Ito, Kunihiro Ikuta, Tomohisa Sakai, and Shiro Imagama.
2023. "Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo" International Journal of Molecular Sciences 24, no. 15: 12422.
https://doi.org/10.3390/ijms241512422
APA Style
Zhang, J., Nishida, Y., Koike, H., Zhuo, L., Ito, K., Ikuta, K., Sakai, T., & Imagama, S.
(2023). Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo. International Journal of Molecular Sciences, 24(15), 12422.
https://doi.org/10.3390/ijms241512422